For research use only. Not for therapeutic Use.
Monomethyl auristatin E intermediate-14 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs)[1].
Catalog Number | I040444 |
CAS Number | 1932791-56-4 |
Synonyms | (2R,3S)-2-(benzylamino)-3-methylpentanoic acid |
Molecular Formula | C13H19NO2 |
Purity | ≥95% |
InChI | InChI=1S/C13H19NO2/c1-3-10(2)12(13(15)16)14-9-11-7-5-4-6-8-11/h4-8,10,12,14H,3,9H2,1-2H3,(H,15,16)/t10-,12+/m0/s1 |
InChIKey | GPAVORZIWQTJJQ-CMPLNLGQSA-N |
SMILES | CCC(C)C(C(=O)O)NCC1=CC=CC=C1 |
Reference | [1]. Lisa Buckel, et al. Tumor radiosensitization by monomethyl auristatin E: mechanism of action and targeted delivery. Cancer Res. 2015 Apr 1;75(7):1376-87. |